Patent ID: 11858937
Assignee: LEAD DISCOVERY CENTER GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 4:
5. The compound according to claim 1, wherein the compound has Formula IV:, or a pharmaceutically acceptable salt or stereoisomer thereof,
wherein:
X1 is CR10;
R10 is H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, or OR5, wherein the C1-C6 alkyl is optionally substituted with one substituent selected from the group consisting of NHR5 and OR5;
Yb is a ring selected from the following Group F:, each R26 is independently H, halogen, C1-C6 alkyl, C(O)NH2, NR5R5, NHC(O)R5, OR5, heterocyclyl, aryl, or heteroaryl, wherein each C1-C6 alkyl is optionally and independently substituted with one substituent selected from the group consisting of NH2 and OH; and
each R27 is independently H, halogen, C1-C6 alkyl, C(O)NH2, NR5R5, NHC(O)R5, OR5, heterocyclyl, aryl, or heteroaryl, wherein each C1-C6 alkyl is optionally and independently substituted with one substituent selected from the group consisting of NH2 and OH.